Zogenix Inc. buy melinda
Start price
22.06.17
/
50%
€13.44
Target price
29.09.17
€30.00
Performance (%)
79.10%
End price
29.09.17
€24.07
Summary
This prediction ended on 29.09.17 with a price of €24.07. With a performance of 79.10% the BUY prediction by melinda was a big success. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Zogenix Inc. | - | - | - | - |
iShares Core DAX® | -0.315% | -2.776% | 12.361% | 15.821% |
iShares Nasdaq 100 | 1.250% | 7.480% | 34.131% | 57.547% |
iShares Nikkei 225® | -1.284% | -2.199% | 5.146% | 3.302% |
iShares S&P 500 | 1.141% | 4.717% | 28.724% | 51.350% |
Comments by melinda for this prediction
In the thread Zogenix Inc. diskutieren
Gesundheit | Hersteller von Medikamenten - Erhebliche | Vereinigte Staaten
* Zogenix Inc. - 22. Juni erteilte die US FDA seine experimentelle Droge, die Ausweisung von Orphan - ZX008 Medikament für die Behandlung von Lennox-Gastaut - Syndrom
(Vom Mitglied beendet)